ARCHIVIO PREMIO TRIVELLA > Elenco vincitori “Premio Piero Trivella”


1998 15-17 novembre, Roma
Alessandra Gasbarri - Differential expression of CD44V6 isoforms and Galectin-3 in benign and malignant thyroid lesions. Potential diagnostic implications
Patrizia Pisarra - Identification of an alternative transcript encoding a putative soluble form of tyrosinase-related protein-2

1999 22-24 novembre, Milano
Marina De Rosa - Mutations in the PMS2 gene cause autosomal recessive Turcot Syndrome
Laura Rosanò - Endothelin-1 upregulates vascular endothelial growth factor production and stimulates ovarian tumor cell proliferation and invasion

2000 5-7 ottobre, Torino
Davide Bisacchi - Human chorionic ?-gonadotropin has anti-angiogenic properties in vivo
Paola Zancai - Glucocorticoids promote the proliferation and antagonize retinoic acid-mediated growth suppression of ABV-immortalized B lymphocytes

2001 10-13 ottobre, Napoli
Chiara Colombo - Characterization of the TRP-2-INT2 antigen, a cytoplasmic novel protein specifically expressed by transformed but not normal cells of the melanocytic lineage
Roberta Venè - Green tea polyphenol effects on angiogenic tumour growth

2002 27-30 ottobre, Genova
Raffaella Dell'Eva - Il-12 gene transfer an approach to uveal melanoma therapy
Luca Roz - Analysis of the apoptotic pathway induced by the fhit protein in the lung cancer cell line H460

2003 9-12 novembre, Bergamo
Francesca Andriani - Microarray analysis of the gene expression profile induced by the FHIT protein
Davide Melisi - Zoledronic acid (Zometa) in combination with a COX-2 inhibitor and gefitinib ('Iressa') cooperatively inhibits growth and angiogenic factor expression in breast and prostate carcinoma cells

2004 24-27 ottobre, Pisa
Alessandra Aloisi - P73 mediates the apoptotic activity of a nuclear BCR-ABL tyrosine kinase
Sabrina Cattaruzza - Role of NG2 proteoglycan in the convergent integrin-independent and FGF signalling events in soft tissue sarcoma cells

2005 2-5 ottobre, Padova – Abano Terme
Katiuscia Bonezzi - Induction of tubulin acetilation by IDN 5390: a possible mechanism of its antimotility activity
Luisa Novellino - Protein-tyrosine phosphatase receptor K (PTPRK) counteracts melanoma

2006 1-4 ottobre, Bari
Stefania Berton - Role of P27kip1 in v-SRC dependent transformation
Carmen Ghilardi - Identification of novel markers of tumor endothelium

2007 26-29 novembre, Pordenone
Daniela Trisciuoglio - The N-terminal BH4 domain of bcl-2 is required for the proangiogenic properties of bcl-2
Alessandra Petrucco - EMILIN plays protective role in multistep skin carcinogenesis

2008 6-9 ottobre, Napoli
Carmine Carbone - Tissue transglutaminase is implicated in the antiproliferative and proapoptotic effect induced by the histone deacetylase inhibitor vorinostat
Federica Maione - Role of semaphorin 3A in tumor angiogenesis in transgenic mouse models of carcinogenesis

2009 23-26 novembre, Sesto San Giovanni (Milano)
Teresa Gelardi - mTOR inhibitor, everolimus, synergizes with a toll-like receptor 9 (TLR9) agonist, IMO, to inhibitor renal cell carcinoma
Rosaria Cammarota - Role of tumor microenvironment in colon-rectal disease

2010 4-7 ottobre, Roma
Chiara Gabellini - Involvement of BH4 domain of bcl-2 and MAPK pathway in the regulation of HIF-1? stability in hypoxic melanoma cells.
Elena Ghiso - Activation of HER family members in gastric carcinoma cells mediates resistance to MET inhibition

2011 19-22 ottobre, Torino
Anna Rita Cantelmo - Metreceptor and angiogenesis: new inhibitors and mechanisms
Paola Romeo - Dusp6/mkp overexpression in papillarythyroid carcinoma

2012 1-4 ottobre, Bologna
Marta Cesca - Proper scheduling of chemotherapy regimens to counteract tumor metastasis after inhibition of angiogenesis
Stefania Capano - Zoledronic acid targets tumor-associated macrophages to overcome the resistance to the anti-angiogenic therapy in a mouse model of spontaneous cervical cancer

2013 23-26 settembre, Catanzaro
Carmela De Marco - AKT1-E17K is oncogenic in mouse and human lung through p27 delocalization 
Federica Capozzi - PARP-1 inhibition potentiates the antitumor and antimetastatic activity of trabectedin in preclinical models of bone and soft tissue sarcomas

2014 11-13 Settembre, Ferrara

Federica Turdo - CDCP1 as a marker of aggressiveness in triple-negative breast cancer
Denise Pinessi - Thrombospondin-1 TS3R domain potentiates response to chemotherapy of human ovarian carcinoma by increasing drug delivery into tumors

2015 20-23 giugno, Firenze

Anastasia De Luca - A novel water-soluble nitrobenzoxadiazole is highly effective against vemurafenib-resistant human mel noma cells

Martina Di Modica - Role of exosome-associated miR-939 in breast cancer metastatic process

2016, 5 - 8 settembre, Verona

Claudia Contadini - Characterization of species-specific and tumor-related differences in p53 centrosomal localization and activities

Martina Magni - DBC1: a protein with multiple roles in DNA damage response and cancer cell growth

2017, 24 - 27 giugno, Firenze

Marta Giussani - Role of extracellular matrix-tumor cell interaction in breast cancer aggressiveness

2018, 19 - 22 Settembre, Milano

Marina Bacci - Amino acids metabolic reprogramming sustains endocrine therapy resistance of er+breast cancer [curriculum vitae]

Elisabetta Valentini - Semaphorine 5A drives melanoma progression: role of MIR-204 and C-MYB. [curriculum vitae]

2019, 6 - 8 novembre, Napoli

Giorgia Mungo - Loss of p27 Kip1 promotes Δ16HER2-induced breast cancer development by both cell autonomous and non-autonomous functions

Elisabeth Digifico - Tumor Associated Macrophages: Toward a Better Understanding of Their Cancer Driver Capability In Malignant Pleural Mesothelioma

2020, 3 - 4 Dicembre, on line

Giulia Siravegna